x

PharmaCyte Biotech, Inc. (Nasdaq:PMCB)

N/A • N/A
CIK 1157075
Company

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.

Address
N/A
Employees
None
Stock Info
Close
$2.0300
Day Range
2.0201 - 2.0900
52 Week Range
1.9200 - 3.2300
Average volume
15.49K
Short Interest
25.36K (02/15/24)
% of Float Shorted
0.34%
Market Cap
$17.66M
Revenue
N/A
Net Income
N/A
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.5834
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
SEC filings
DateFormEvent
13 Dec, 2024 10-Q
4 Dec, 2024 S-8
13 Nov, 2024 SC 13G/A
17 Sep, 2024 NT 10-Q
17 Sep, 2024 10-Q
13 Aug, 2024 10-K
29 Jul, 2024 NT 10-K
17 Jul, 2024 4
17 Jul, 2024 4
17 Jul, 2024 4
17 Jul, 2024 4
30 May, 2024 SC 13D
30 May, 2024 3
23 May, 2024 8-K
1 May, 2024 8-K
27 Mar, 2024 ARS
27 Mar, 2024 DEF 14A
18 Mar, 2024 10-Q
14 Feb, 2024 SC 13G
6 Feb, 2024 SC 13G/A
15 Dec, 2023 10-Q
28 Nov, 2023 3
24 Nov, 2023 8-K
22 Nov, 2023 4
22 Nov, 2023 SC 13D
22 Nov, 2023 4
22 Nov, 2023 4
22 Nov, 2023 4
22 Nov, 2023 4
22 Nov, 2023 4
16 Nov, 2023 8-K
9 Nov, 2023 8-K
29 Sep, 2023 EFFECT
27 Sep, 2023 CORRESP
21 Sep, 2023 S-3/A
18 Sep, 2023 10-Q
15 Sep, 2023 NT 10-Q
12 Sep, 2023 S-3/A
7 Sep, 2023 8-K
4 Aug, 2023 8-K
4 Aug, 2023 CORRESP
4 Aug, 2023 S-3/A
31 Jul, 2023 DEF 14A
31 Jul, 2023 10-K
19 Jul, 2023 8-K
19 Jul, 2023 PRE 14A
26 Jun, 2023 UPLOAD
16 Jun, 2023 SC 13D/A
15 Jun, 2023 SC TO-I/A
9 Jun, 2023 S-3
5 Jun, 2023 CORRESP
5 Jun, 2023 DEF 14A
30 May, 2023 CORRESP
25 May, 2023 PRE 14A
19 May, 2023 UPLOAD
19 May, 2023 SC 13G
12 May, 2023 SC 13D/A
11 May, 2023 SC TO-I
11 May, 2023 8-K
16 Mar, 2023 10-Q
14 Feb, 2023 SC 13G/A
8 Feb, 2023 SC 13G/A
2 Feb, 2023 8-K
10 Jan, 2023 SC 13G/A
30 Dec, 2022 8-K
30 Dec, 2022 4
30 Dec, 2022 4
30 Dec, 2022 3
14 Dec, 2022 10-Q
18 Nov, 2022 8-K
16 Nov, 2022 3
15 Nov, 2022 PRE 14A
7 Nov, 2022 8-K
20 Oct, 2022 SC 13G
14 Oct, 2022 8-K
7 Oct, 2022 8-K CEO Change
14 Sep, 2022 10-Q
24 Aug, 2022 3
23 Aug, 2022 3
23 Aug, 2022 3
23 Aug, 2022 3
23 Aug, 2022 3
16 Aug, 2022 DEFA14A
16 Aug, 2022 8-K
15 Aug, 2022 SC 13D/A
28 Jul, 2022 10-K
28 Jul, 2022 8-K
28 Jul, 2022 DFAN14A
28 Jul, 2022 DEFA14A
26 Jul, 2022 PREC14A
21 Jul, 2022 8-K
21 Jul, 2022 DEFA14A
19 Jul, 2022 8-K
19 Jul, 2022 DEFA14A
11 Jul, 2022 DEFA14A
11 Jul, 2022 8-K
11 Jul, 2022 SC 13D/A
11 Jul, 2022 DFAN14A
5 Jul, 2022 DFAN14A
23 Jun, 2022 SC 13D/A
23 Jun, 2022 DFAN14A
15 Jun, 2022 8-K
15 Jun, 2022 DEFA14A
7 Jun, 2022 8-K
13 Apr, 2022 8-K
11 Apr, 2022 3
5 Apr, 2022 8-K
15 Mar, 2022 10-Q
9 Mar, 2022 8-K
1 Mar, 2022 8-K
17 Feb, 2022 8-K
11 Feb, 2022 SC 13G/A
4 Jan, 2022 SC 13G/A
14 Dec, 2021 10-Q
22 Nov, 2021 424B3
17 Nov, 2021 EFFECT
15 Nov, 2021 UPLOAD
15 Nov, 2021 CORRESP
8 Nov, 2021 S-3
4 Nov, 2021 SC 13D
14 Sep, 2021 10-Q
10 Sep, 2021 8-K
3 Sep, 2021 3
1 Sep, 2021 D
31 Aug, 2021 3
31 Aug, 2021 3
31 Aug, 2021 3
30 Aug, 2021 SC 13G
30 Aug, 2021 SC 13G
23 Aug, 2021 424B5
23 Aug, 2021 8-K
20 Aug, 2021 3
20 Aug, 2021 3
20 Aug, 2021 3
19 Aug, 2021 S-3MEF
12 Aug, 2021 8-K
10 Aug, 2021 CERT
10 Aug, 2021 424B5
10 Aug, 2021 10-K
2 Aug, 2021 424B5
2 Aug, 2021 8-K
2 Aug, 2021 8-A12B
29 Jul, 2021 NT 10-K
13 Jul, 2021 8-K
6 Jul, 2021 8-K
22 Jun, 2021 8-K
15 Jun, 2021 8-K
4 Jun, 2021 8-K
6 May, 2021 8-K
14 Apr, 2021 EFFECT
12 Apr, 2021 CORRESP
9 Apr, 2021 UPLOAD
5 Apr, 2021 S-3
12 Mar, 2021 10-Q
Last update:2024-03-06 12:43:23.760298
PharmaCyte Biotech, Inc. by TradingView

Sign Up to Subscribe